

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.70920687 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 4.67887428 |
| 3 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.58773484 |
| 4 | establishment of mitochondrion localization (GO:0051654) | 4.50777825 |
| 5 | axonal fasciculation (GO:0007413) | 4.46719813 |
| 6 | synaptic vesicle exocytosis (GO:0016079) | 4.45592225 |
| 7 | neuron recognition (GO:0008038) | 4.37687953 |
| 8 | vocalization behavior (GO:0071625) | 4.22488757 |
| 9 | cell migration in hindbrain (GO:0021535) | 4.20144742 |
| 10 | postsynaptic membrane organization (GO:0001941) | 4.19333614 |
| 11 | protein localization to synapse (GO:0035418) | 4.15799481 |
| 12 | presynaptic membrane organization (GO:0097090) | 4.11891007 |
| 13 | regulation of synaptic vesicle transport (GO:1902803) | 4.01020565 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.97152955 |
| 15 | mitochondrion transport along microtubule (GO:0047497) | 3.91480694 |
| 16 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.91480694 |
| 17 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.87474718 |
| 18 | layer formation in cerebral cortex (GO:0021819) | 3.86102387 |
| 19 | presynaptic membrane assembly (GO:0097105) | 3.85396788 |
| 20 | cerebellar granule cell differentiation (GO:0021707) | 3.82344307 |
| 21 | neurotransmitter secretion (GO:0007269) | 3.82049092 |
| 22 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.76537198 |
| 23 | neuronal ion channel clustering (GO:0045161) | 3.72840375 |
| 24 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.68824972 |
| 25 | regulation of synapse structural plasticity (GO:0051823) | 3.63922629 |
| 26 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.63027559 |
| 27 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.62819824 |
| 28 | auditory behavior (GO:0031223) | 3.61908636 |
| 29 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 3.61122080 |
| 30 | exploration behavior (GO:0035640) | 3.55849740 |
| 31 | synapse assembly (GO:0007416) | 3.48510559 |
| 32 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.43972277 |
| 33 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.37011583 |
| 34 | substrate-independent telencephalic tangential migration (GO:0021826) | 3.34659975 |
| 35 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 3.34659975 |
| 36 | glutamate receptor signaling pathway (GO:0007215) | 3.34344160 |
| 37 | neuron-neuron synaptic transmission (GO:0007270) | 3.27346112 |
| 38 | synaptic transmission, glutamatergic (GO:0035249) | 3.26693539 |
| 39 | mechanosensory behavior (GO:0007638) | 3.24838485 |
| 40 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.23852482 |
| 41 | growth hormone receptor signaling pathway (GO:0060396) | 3.23598893 |
| 42 | cell differentiation in hindbrain (GO:0021533) | 3.22727411 |
| 43 | positive regulation of membrane potential (GO:0045838) | 3.20989446 |
| 44 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.20567917 |
| 45 | positive regulation of synapse assembly (GO:0051965) | 3.19817652 |
| 46 | transmission of nerve impulse (GO:0019226) | 3.19734059 |
| 47 | neurofilament cytoskeleton organization (GO:0060052) | 3.19238358 |
| 48 | cerebral cortex radially oriented cell migration (GO:0021799) | 3.18604996 |
| 49 | protein localization to endosome (GO:0036010) | 3.14613895 |
| 50 | positive regulation of synapse maturation (GO:0090129) | 3.13660445 |
| 51 | negative regulation of microtubule polymerization (GO:0031115) | 3.12394747 |
| 52 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.08825897 |
| 53 | gamma-aminobutyric acid transport (GO:0015812) | 3.07179657 |
| 54 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.06060388 |
| 55 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.03623600 |
| 56 | regulation of postsynaptic membrane potential (GO:0060078) | 3.00754904 |
| 57 | synaptic vesicle maturation (GO:0016188) | 3.00618297 |
| 58 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.00515217 |
| 59 | organelle transport along microtubule (GO:0072384) | 2.99826147 |
| 60 | regulation of vesicle fusion (GO:0031338) | 2.99708288 |
| 61 | sodium ion export (GO:0071436) | 2.99510229 |
| 62 | neurotransmitter transport (GO:0006836) | 2.98856820 |
| 63 | dendritic spine organization (GO:0097061) | 2.97425507 |
| 64 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.96715836 |
| 65 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.93682158 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 2.92453661 |
| 67 | neuronal action potential propagation (GO:0019227) | 2.92321759 |
| 68 | dopamine receptor signaling pathway (GO:0007212) | 2.92044946 |
| 69 | adult walking behavior (GO:0007628) | 2.89182778 |
| 70 | alpha-linolenic acid metabolic process (GO:0036109) | 2.88579207 |
| 71 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.88115427 |
| 72 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.86762470 |
| 73 | establishment of nucleus localization (GO:0040023) | 2.86617519 |
| 74 | response to auditory stimulus (GO:0010996) | 2.84384808 |
| 75 | positive regulation of histone deacetylation (GO:0031065) | 2.83686417 |
| 76 | regulation of neurotransmitter levels (GO:0001505) | 2.83574527 |
| 77 | cellular response to growth hormone stimulus (GO:0071378) | 2.82769208 |
| 78 | spinal cord association neuron differentiation (GO:0021527) | 2.78283260 |
| 79 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.77573595 |
| 80 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.77546020 |
| 81 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.77268219 |
| 82 | regulation of neurotransmitter secretion (GO:0046928) | 2.77153387 |
| 83 | neuromuscular synaptic transmission (GO:0007274) | 2.76876145 |
| 84 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.76768597 |
| 85 | synapse organization (GO:0050808) | 2.75733992 |
| 86 | positive regulation of dendritic spine development (GO:0060999) | 2.75368386 |
| 87 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.72998930 |
| 88 | behavioral defense response (GO:0002209) | 2.72879929 |
| 89 | behavioral fear response (GO:0001662) | 2.72879929 |
| 90 | dendrite development (GO:0016358) | 2.72343854 |
| 91 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.71423752 |
| 92 | behavioral response to cocaine (GO:0048148) | 2.70810663 |
| 93 | membrane depolarization during action potential (GO:0086010) | 2.70537473 |
| 94 | clathrin coat assembly (GO:0048268) | 2.69499129 |
| 95 | negative regulation of axonogenesis (GO:0050771) | 2.69327114 |
| 96 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.65600177 |
| 97 | membrane depolarization (GO:0051899) | 2.64863130 |
| 98 | response to histamine (GO:0034776) | 2.64622027 |
| 99 | positive regulation of fatty acid oxidation (GO:0046321) | 2.64186008 |
| 100 | regulation of synapse maturation (GO:0090128) | 2.63030410 |
| 101 | neuron projection extension (GO:1990138) | 2.63027245 |
| 102 | locomotory exploration behavior (GO:0035641) | 2.60639092 |
| 103 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.60401419 |
| 104 | activation of protein kinase A activity (GO:0034199) | 2.57129677 |
| 105 | nerve growth factor signaling pathway (GO:0038180) | 2.55467005 |
| 106 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.54334409 |
| 107 | nucleobase catabolic process (GO:0046113) | 2.53266394 |
| 108 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.52005068 |
| 109 | germ cell migration (GO:0008354) | 2.44699693 |
| 110 | glial cell proliferation (GO:0014009) | 2.40926977 |
| 111 | cellular potassium ion homeostasis (GO:0030007) | 2.40708256 |
| 112 | membrane repolarization during action potential (GO:0086011) | 2.38777453 |
| 113 | regulation of ARF protein signal transduction (GO:0032012) | 2.36726031 |
| 114 | negative regulation of fatty acid transport (GO:2000192) | 2.34960048 |
| 115 | dendrite morphogenesis (GO:0048813) | 2.34874856 |
| 116 | regulation of fatty acid oxidation (GO:0046320) | 2.33455725 |
| 117 | lysine catabolic process (GO:0006554) | 2.29114108 |
| 118 | lysine metabolic process (GO:0006553) | 2.29114108 |
| 119 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.29011059 |
| 120 | dendritic spine morphogenesis (GO:0060997) | 2.27001670 |
| 121 | regulation of ARF GTPase activity (GO:0032312) | 2.26116626 |
| 122 | peptidyl-lysine dimethylation (GO:0018027) | 2.26057039 |
| 123 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.24505891 |
| 124 | low-density lipoprotein particle clearance (GO:0034383) | 2.24473199 |
| 125 | positive regulation of lipid catabolic process (GO:0050996) | 2.23018171 |
| 126 | regulation of cholesterol homeostasis (GO:2000188) | 2.22800559 |
| 127 | regulation of polysaccharide biosynthetic process (GO:0032885) | 2.22239260 |
| 128 | regulation of cholesterol storage (GO:0010885) | 2.21723860 |
| 129 | acylglycerol catabolic process (GO:0046464) | 2.20432070 |
| 130 | neutral lipid catabolic process (GO:0046461) | 2.20432070 |
| 131 | proline transport (GO:0015824) | 2.19905061 |
| 132 | alanine transport (GO:0032328) | 2.19810618 |
| 133 | peptidyl-threonine modification (GO:0018210) | 2.17837787 |
| 134 | negative regulation of catenin import into nucleus (GO:0035414) | 2.16915093 |
| 135 | triglyceride catabolic process (GO:0019433) | 2.16063306 |
| 136 | mating behavior (GO:0007617) | 2.15190025 |
| 137 | potassium ion import (GO:0010107) | 2.14787721 |
| 138 | negative regulation of cell size (GO:0045792) | 2.12759782 |
| 139 | signal complex assembly (GO:0007172) | 2.12735343 |
| 140 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.12706941 |
| 141 | glucocorticoid receptor signaling pathway (GO:0042921) | 2.09519310 |
| 142 | response to nerve growth factor (GO:1990089) | 2.09226950 |
| 143 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.09226950 |
| 144 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.08933195 |
| 145 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.08848397 |
| 146 | positive regulation of glycogen metabolic process (GO:0070875) | 2.08759008 |
| 147 | negative regulation of heart growth (GO:0061117) | 2.05547061 |
| 148 | negative regulation of cardiac muscle tissue growth (GO:0055022) | 2.05547061 |
| 149 | membrane repolarization (GO:0086009) | 2.05118835 |
| 150 | regulation of glycogen (starch) synthase activity (GO:2000465) | 2.04554919 |
| 151 | regulation of sequestering of triglyceride (GO:0010889) | 2.04414041 |
| 152 | glutamate secretion (GO:0014047) | 2.04197897 |
| 153 | peptidyl-threonine phosphorylation (GO:0018107) | 2.03451066 |
| 154 | hypotonic response (GO:0006971) | 2.03123527 |
| 155 | regulation of NFAT protein import into nucleus (GO:0051532) | 2.02869172 |
| 156 | valine metabolic process (GO:0006573) | 2.02831428 |
| 157 | regulation of p38MAPK cascade (GO:1900744) | 2.02256328 |
| 158 | positive regulation of glucose import (GO:0046326) | 2.01904734 |
| 159 | fatty acid transmembrane transport (GO:1902001) | 2.00468748 |
| 160 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.00449123 |
| 161 | protein targeting to Golgi (GO:0000042) | 2.00146332 |
| 162 | receptor catabolic process (GO:0032801) | 1.99440096 |
| 163 | positive regulation of nitric-oxide synthase activity (GO:0051000) | 1.99078597 |
| 164 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 1.98250558 |
| 165 | cell communication by electrical coupling (GO:0010644) | 1.97932196 |
| 166 | carnitine shuttle (GO:0006853) | 1.97575595 |
| 167 | tricarboxylic acid metabolic process (GO:0072350) | 1.95291446 |
| 168 | establishment of protein localization to Golgi (GO:0072600) | 1.94875019 |
| 169 | cellular response to lithium ion (GO:0071285) | 1.93870769 |
| 170 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 1.93387706 |
| 171 | hippo signaling (GO:0035329) | 1.92669614 |
| 172 | macroautophagy (GO:0016236) | 1.91933038 |
| 173 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 1.91644117 |
| 174 | stress fiber assembly (GO:0043149) | 1.91243674 |
| 175 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 1.91203952 |
| 176 | 4-hydroxyproline metabolic process (GO:0019471) | 1.90874238 |
| 177 | suckling behavior (GO:0001967) | 1.90622860 |
| 178 | lipid translocation (GO:0034204) | 1.90031783 |
| 179 | phospholipid translocation (GO:0045332) | 1.90031783 |
| 180 | amino-acid betaine transport (GO:0015838) | 1.89601827 |
| 181 | carnitine transport (GO:0015879) | 1.89601827 |
| 182 | axon extension (GO:0048675) | 1.89109128 |
| 183 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 1.88785176 |
| 184 | positive regulation of axon extension (GO:0045773) | 1.88059107 |
| 185 | cellular sodium ion homeostasis (GO:0006883) | 1.87997824 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 4.00326650 |
| 2 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.84836329 |
| 3 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.66185275 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.53659353 |
| 5 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.45247306 |
| 6 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 2.33453097 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.31945426 |
| 8 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.26941575 |
| 9 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.12181139 |
| 10 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.10943163 |
| 11 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.05652039 |
| 12 | RNF2_27304074_Chip-Seq_NSC_Mouse | 2.03632562 |
| 13 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01315745 |
| 14 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.92170540 |
| 15 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.88810375 |
| 16 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.86189521 |
| 17 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.81133451 |
| 18 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.80648780 |
| 19 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72479185 |
| 20 | KDM2B_26808549_Chip-Seq_K562_Human | 1.72305452 |
| 21 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.71770021 |
| 22 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.71695313 |
| 23 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.70999109 |
| 24 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.67588985 |
| 25 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.65701987 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.64949823 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.62283507 |
| 28 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.61959790 |
| 29 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.61424039 |
| 30 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.60299069 |
| 31 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.57860048 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.57485109 |
| 33 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.54681457 |
| 34 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.53744589 |
| 35 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.53101036 |
| 36 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.51508765 |
| 37 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.50785161 |
| 38 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.47321591 |
| 39 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.45915537 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.45150580 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.45150580 |
| 42 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.44437050 |
| 43 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43976755 |
| 44 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.43841981 |
| 45 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43144589 |
| 46 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.43144589 |
| 47 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.42502277 |
| 48 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.42335618 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41810896 |
| 50 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.41231258 |
| 51 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.39152519 |
| 52 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.38796713 |
| 53 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.37841309 |
| 54 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.35371102 |
| 55 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.34808547 |
| 56 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.34208210 |
| 57 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.33624927 |
| 58 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31312061 |
| 59 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.30736089 |
| 60 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29952254 |
| 61 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29785125 |
| 62 | * FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.29015223 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.28218175 |
| 64 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.28015025 |
| 65 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.26330238 |
| 66 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.25974860 |
| 67 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.25763061 |
| 68 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.25126708 |
| 69 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.25113377 |
| 70 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.24987426 |
| 71 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.24941677 |
| 72 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.24861880 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.24182472 |
| 74 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23989876 |
| 75 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.23350869 |
| 76 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.23115379 |
| 77 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.22773006 |
| 78 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.22410930 |
| 79 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.21189140 |
| 80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.19608408 |
| 81 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.19013005 |
| 82 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17157055 |
| 83 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.16729027 |
| 84 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16450212 |
| 85 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.16351629 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.15643113 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.15219620 |
| 88 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.14472507 |
| 89 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.14276814 |
| 90 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.14031616 |
| 91 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.13756036 |
| 92 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.13208789 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13199760 |
| 94 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13123168 |
| 95 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.13011696 |
| 96 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12588300 |
| 97 | P300_19829295_ChIP-Seq_ESCs_Human | 1.12319761 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11384209 |
| 99 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.10274806 |
| 100 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.09262965 |
| 101 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.09262965 |
| 102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.09146753 |
| 103 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.08837833 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.08705193 |
| 105 | * STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08653063 |
| 106 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.08177637 |
| 107 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.07141873 |
| 108 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.07122086 |
| 109 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.06872779 |
| 110 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.06562680 |
| 111 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.06159066 |
| 112 | FUS_26573619_Chip-Seq_HEK293_Human | 1.05915655 |
| 113 | * NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05783810 |
| 114 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.05490579 |
| 115 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05320716 |
| 116 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.05120393 |
| 117 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04685107 |
| 118 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04434590 |
| 119 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03347747 |
| 120 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.02792438 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02598444 |
| 122 | * TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.02394132 |
| 123 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.02203351 |
| 124 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.00953989 |
| 125 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00861825 |
| 126 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.00162505 |
| 127 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99323841 |
| 128 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.98828630 |
| 129 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97406184 |
| 130 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97153504 |
| 131 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.97134112 |
| 132 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97031021 |
| 133 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96835401 |
| 134 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.96651194 |
| 135 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.96521136 |
| 136 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.96186555 |
| 137 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96100820 |
| 138 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95721298 |
| 139 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95718357 |
| 140 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.95506372 |
| 141 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95444749 |
| 142 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.95382181 |
| 143 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.94940422 |
| 144 | STAT3_23295773_ChIP-Seq_U87_Human | 0.94729575 |
| 145 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.94393853 |
| 146 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.93818336 |
| 147 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.93689241 |
| 148 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93678952 |
| 149 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.93126311 |
| 150 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91954133 |
| 151 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.91856189 |
| 152 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.91601522 |
| 153 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.91331419 |
| 154 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91132110 |
| 155 | STAT3_18555785_ChIP-Seq_MESCs_Mouse | 0.91000222 |
| 156 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.90405936 |
| 157 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.90199116 |
| 158 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.90123813 |
| 159 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89739630 |
| 160 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.89627648 |
| 161 | AR_19668381_ChIP-Seq_PC3_Human | 0.89558471 |
| 162 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.89312532 |
| 163 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 0.89253797 |
| 164 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.88378261 |
| 165 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88222529 |
| 166 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.87631803 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0010234_abnormal_vibrissa_follicle | 5.06860039 |
| 2 | MP0003880_abnormal_central_pattern | 4.47645461 |
| 3 | MP0005423_abnormal_somatic_nervous | 3.53821594 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.46453832 |
| 5 | MP0003787_abnormal_imprinting | 3.44617259 |
| 6 | MP0002822_catalepsy | 3.21908298 |
| 7 | MP0003122_maternal_imprinting | 3.08454222 |
| 8 | MP0003300_gastrointestinal_ulcer | 3.06694433 |
| 9 | MP0008961_abnormal_basal_metabolism | 2.93381292 |
| 10 | MP0004185_abnormal_adipocyte_glucose | 2.72075145 |
| 11 | MP0004130_abnormal_muscle_cell | 2.60466346 |
| 12 | MP0002139_abnormal_hepatobiliary_system | 2.59063824 |
| 13 | MP0004859_abnormal_synaptic_plasticity | 2.49597532 |
| 14 | MP0002064_seizures | 2.39780262 |
| 15 | MP0003121_genomic_imprinting | 2.39710836 |
| 16 | MP0009780_abnormal_chondrocyte_physiolo | 2.39501434 |
| 17 | MP0009745_abnormal_behavioral_response | 2.38220536 |
| 18 | MP0000569_abnormal_digit_pigmentation | 2.29927129 |
| 19 | MP0002572_abnormal_emotion/affect_behav | 2.28245070 |
| 20 | MP0005360_urolithiasis | 2.24724599 |
| 21 | MP0002272_abnormal_nervous_system | 2.24512674 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.24055814 |
| 23 | MP0005666_abnormal_adipose_tissue | 2.20280293 |
| 24 | MP0001188_hyperpigmentation | 2.17686051 |
| 25 | MP0002909_abnormal_adrenal_gland | 2.16154191 |
| 26 | MP0002734_abnormal_mechanical_nocicepti | 2.14140517 |
| 27 | MP0001486_abnormal_startle_reflex | 2.10130828 |
| 28 | MP0002735_abnormal_chemical_nociception | 2.05863301 |
| 29 | MP0003303_peritoneal_inflammation | 1.99107334 |
| 30 | MP0009046_muscle_twitch | 1.95321330 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.92290809 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.90928473 |
| 33 | MP0003123_paternal_imprinting | 1.85516477 |
| 34 | MP0003252_abnormal_bile_duct | 1.84296339 |
| 35 | MP0003890_abnormal_embryonic-extraembry | 1.83877655 |
| 36 | MP0002557_abnormal_social/conspecific_i | 1.78712452 |
| 37 | MP0005375_adipose_tissue_phenotype | 1.74483157 |
| 38 | MP0001984_abnormal_olfaction | 1.74405912 |
| 39 | MP0000955_abnormal_spinal_cord | 1.74176158 |
| 40 | MP0005499_abnormal_olfactory_system | 1.73816746 |
| 41 | MP0005394_taste/olfaction_phenotype | 1.73816746 |
| 42 | MP0005623_abnormal_meninges_morphology | 1.73477351 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.72827383 |
| 44 | MP0000566_synostosis | 1.70245090 |
| 45 | MP0004858_abnormal_nervous_system | 1.67494058 |
| 46 | MP0001968_abnormal_touch/_nociception | 1.66752230 |
| 47 | MP0002067_abnormal_sensory_capabilities | 1.66384603 |
| 48 | MP0002184_abnormal_innervation | 1.65576811 |
| 49 | MP0000537_abnormal_urethra_morphology | 1.62562846 |
| 50 | MP0005167_abnormal_blood-brain_barrier | 1.60043809 |
| 51 | MP0009379_abnormal_foot_pigmentation | 1.59863323 |
| 52 | MP0001970_abnormal_pain_threshold | 1.59615026 |
| 53 | MP0004043_abnormal_pH_regulation | 1.57743887 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.57612244 |
| 55 | MP0010329_abnormal_lipoprotein_level | 1.56712977 |
| 56 | MP0001529_abnormal_vocalization | 1.56673315 |
| 57 | MP0002882_abnormal_neuron_morphology | 1.56652122 |
| 58 | MP0004742_abnormal_vestibular_system | 1.55183042 |
| 59 | MP0002733_abnormal_thermal_nociception | 1.54711032 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 1.54023710 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.52574185 |
| 62 | MP0004924_abnormal_behavior | 1.52574185 |
| 63 | MP0004885_abnormal_endolymph | 1.49898585 |
| 64 | MP0005187_abnormal_penis_morphology | 1.49729269 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.49070141 |
| 66 | MP0004142_abnormal_muscle_tone | 1.48927771 |
| 67 | MP0003191_abnormal_cellular_cholesterol | 1.47963346 |
| 68 | MP0006292_abnormal_olfactory_placode | 1.43463389 |
| 69 | MP0001849_ear_inflammation | 1.39193642 |
| 70 | MP0000003_abnormal_adipose_tissue | 1.35861212 |
| 71 | MP0002152_abnormal_brain_morphology | 1.35174858 |
| 72 | MP0004270_analgesia | 1.31449411 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.28236068 |
| 74 | MP0003938_abnormal_ear_development | 1.28084441 |
| 75 | MP0001501_abnormal_sleep_pattern | 1.26798125 |
| 76 | MP0002234_abnormal_pharynx_morphology | 1.25930848 |
| 77 | MP0005645_abnormal_hypothalamus_physiol | 1.25759534 |
| 78 | MP0010352_gastrointestinal_tract_polyps | 1.23046209 |
| 79 | MP0001905_abnormal_dopamine_level | 1.22481723 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 1.21703641 |
| 81 | MP0002638_abnormal_pupillary_reflex | 1.19731127 |
| 82 | MP0002896_abnormal_bone_mineralization | 1.19068204 |
| 83 | MP0003635_abnormal_synaptic_transmissio | 1.18738993 |
| 84 | MP0000631_abnormal_neuroendocrine_gland | 1.17587088 |
| 85 | MP0005248_abnormal_Harderian_gland | 1.17023658 |
| 86 | MP0003045_fibrosis | 1.15354726 |
| 87 | MP0000013_abnormal_adipose_tissue | 1.14058628 |
| 88 | MP0005085_abnormal_gallbladder_physiolo | 1.12976402 |
| 89 | MP0002971_abnormal_brown_adipose | 1.12706608 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 1.12700600 |
| 91 | MP0003861_abnormal_nervous_system | 1.12150515 |
| 92 | MP0003879_abnormal_hair_cell | 1.11927822 |
| 93 | MP0002752_abnormal_somatic_nervous | 1.10811083 |
| 94 | MP0009053_abnormal_anal_canal | 1.10442858 |
| 95 | MP0003329_amyloid_beta_deposits | 1.09423224 |
| 96 | MP0010678_abnormal_skin_adnexa | 1.09363093 |
| 97 | MP0010368_abnormal_lymphatic_system | 1.08248161 |
| 98 | MP0002736_abnormal_nociception_after | 1.07939536 |
| 99 | MP0005365_abnormal_bile_salt | 1.07283344 |
| 100 | MP0005275_abnormal_skin_tensile | 1.07083013 |
| 101 | MP0002254_reproductive_system_inflammat | 1.06885757 |
| 102 | MP0003091_abnormal_cell_migration | 1.03497556 |
| 103 | MP0003283_abnormal_digestive_organ | 1.02298759 |
| 104 | MP0002653_abnormal_ependyma_morphology | 1.02198839 |
| 105 | MP0001765_abnormal_ion_homeostasis | 1.01431021 |
| 106 | MP0001958_emphysema | 1.00455636 |
| 107 | MP0004133_heterotaxia | 1.00190305 |
| 108 | MP0002063_abnormal_learning/memory/cond | 0.99761889 |
| 109 | MP0000604_amyloidosis | 0.98926564 |
| 110 | MP0003566_abnormal_cell_adhesion | 0.96992693 |
| 111 | MP0002118_abnormal_lipid_homeostasis | 0.96514712 |
| 112 | MP0002009_preneoplasia | 0.96321211 |
| 113 | MP0003075_altered_response_to | 0.95339706 |
| 114 | MP0004272_abnormal_basement_membrane | 0.94165507 |
| 115 | MP0005535_abnormal_body_temperature | 0.93264326 |
| 116 | MP0000026_abnormal_inner_ear | 0.93118925 |
| 117 | MP0008995_early_reproductive_senescence | 0.93031930 |
| 118 | MP0008438_abnormal_cutaneous_collagen | 0.92965875 |
| 119 | MP0002069_abnormal_eating/drinking_beha | 0.92033867 |
| 120 | MP0003690_abnormal_glial_cell | 0.91993249 |
| 121 | MP0000733_abnormal_muscle_development | 0.91281437 |
| 122 | MP0003633_abnormal_nervous_system | 0.90590690 |
| 123 | MP0003631_nervous_system_phenotype | 0.89880352 |
| 124 | MP0005409_darkened_coat_color | 0.89876481 |
| 125 | MP0003195_calcinosis | 0.89337819 |
| 126 | MP0002837_dystrophic_cardiac_calcinosis | 0.88541939 |
| 127 | MP0009278_abnormal_bone_marrow | 0.87895254 |
| 128 | MP0000778_abnormal_nervous_system | 0.87613511 |
| 129 | MP0002166_altered_tumor_susceptibility | 0.85958024 |
| 130 | MP0006054_spinal_hemorrhage | 0.85927240 |
| 131 | MP0005670_abnormal_white_adipose | 0.85719322 |
| 132 | MP0000534_abnormal_ureter_morphology | 0.85715272 |
| 133 | MP0005646_abnormal_pituitary_gland | 0.85545284 |
| 134 | MP0000516_abnormal_urinary_system | 0.85515612 |
| 135 | MP0005367_renal/urinary_system_phenotyp | 0.85515612 |
| 136 | MP0001963_abnormal_hearing_physiology | 0.83666546 |
| 137 | MP0004811_abnormal_neuron_physiology | 0.82884960 |
| 138 | MP0002102_abnormal_ear_morphology | 0.82099695 |
| 139 | MP0004484_altered_response_of | 0.80866243 |
| 140 | MP0002229_neurodegeneration | 0.80407408 |
| 141 | MP0009384_cardiac_valve_regurgitation | 0.78698003 |
| 142 | MP0005551_abnormal_eye_electrophysiolog | 0.77538105 |
| 143 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77534926 |
| 144 | MP0005334_abnormal_fat_pad | 0.76085135 |
| 145 | MP0001177_atelectasis | 0.75636717 |
| 146 | MP0001756_abnormal_urination | 0.74963736 |
| 147 | MP0001943_abnormal_respiration | 0.74156331 |
| 148 | MP0003115_abnormal_respiratory_system | 0.74073608 |
| 149 | MP0002928_abnormal_bile_duct | 0.73549202 |
| 150 | MP0004145_abnormal_muscle_electrophysio | 0.73201815 |
| 151 | MP0008569_lethality_at_weaning | 0.72809085 |
| 152 | MP0010630_abnormal_cardiac_muscle | 0.72794832 |
| 153 | MP0002078_abnormal_glucose_homeostasis | 0.72400211 |
| 154 | MP0001485_abnormal_pinna_reflex | 0.72259155 |
| 155 | MP0000609_abnormal_liver_physiology | 0.70708297 |
| 156 | MP0002751_abnormal_autonomic_nervous | 0.70089329 |
| 157 | MP0002081_perinatal_lethality | 0.69795254 |
| 158 | MP0000049_abnormal_middle_ear | 0.69567808 |
| 159 | MP0004510_myositis | 0.69264792 |
| 160 | MP0009115_abnormal_fat_cell | 0.67750959 |
| 161 | MP0002168_other_aberrant_phenotype | 0.66677509 |
| 162 | MP0002089_abnormal_postnatal_growth/wei | 0.65380071 |
| 163 | MP0006138_congestive_heart_failure | 0.65292027 |
| 164 | MP0004087_abnormal_muscle_fiber | 0.65167881 |
| 165 | * MP0009643_abnormal_urine_homeostasis | 0.64567780 |
| 166 | MP0005166_decreased_susceptibility_to | 0.64079587 |
| 167 | MP0004147_increased_porphyrin_level | 0.63877182 |
| 168 | MP0003119_abnormal_digestive_system | 0.63716363 |
| 169 | MP0003221_abnormal_cardiomyocyte_apopto | 0.63050996 |
| 170 | MP0003942_abnormal_urinary_system | 0.62985695 |
| 171 | MP0001986_abnormal_taste_sensitivity | 0.62642524 |
| 172 | MP0003453_abnormal_keratinocyte_physiol | 0.62533842 |
| 173 | MP0002082_postnatal_lethality | 0.62494860 |
| 174 | MP0010770_preweaning_lethality | 0.62494860 |
| 175 | MP0001270_distended_abdomen | 0.61594436 |
| 176 | MP0001299_abnormal_eye_distance/ | 0.60129226 |
| 177 | MP0003172_abnormal_lysosome_physiology | 0.60128400 |
| 178 | MP0010769_abnormal_survival | 0.59744363 |
| 179 | MP0003632_abnormal_nervous_system | 0.59223289 |
| 180 | MP0010768_mortality/aging | 0.56940235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.25916477 |
| 2 | Limb dystonia (HP:0002451) | 5.41361205 |
| 3 | Focal motor seizures (HP:0011153) | 4.29247308 |
| 4 | Focal seizures (HP:0007359) | 4.07154415 |
| 5 | Febrile seizures (HP:0002373) | 3.99882313 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.91762273 |
| 7 | Polyphagia (HP:0002591) | 3.84706797 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 3.68731138 |
| 9 | Atonic seizures (HP:0010819) | 3.51021178 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.50350229 |
| 11 | Abnormal eating behavior (HP:0100738) | 3.43983423 |
| 12 | Drooling (HP:0002307) | 3.41183032 |
| 13 | Excessive salivation (HP:0003781) | 3.25269933 |
| 14 | Macroorchidism (HP:0000053) | 3.20471308 |
| 15 | Supranuclear gaze palsy (HP:0000605) | 3.15921052 |
| 16 | Sleep apnea (HP:0010535) | 3.10776115 |
| 17 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.09734320 |
| 18 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.09734320 |
| 19 | Amyotrophic lateral sclerosis (HP:0007354) | 3.02655456 |
| 20 | Subacute progressive viral hepatitis (HP:0006572) | 2.93286923 |
| 21 | Spastic gait (HP:0002064) | 2.88040339 |
| 22 | Lymphangioma (HP:0100764) | 2.79001473 |
| 23 | Diplopia (HP:0000651) | 2.78171563 |
| 24 | Abnormality of binocular vision (HP:0011514) | 2.78171563 |
| 25 | Generalized tonic-clonic seizures (HP:0002069) | 2.77768296 |
| 26 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.77657936 |
| 27 | Broad-based gait (HP:0002136) | 2.77120561 |
| 28 | Epileptiform EEG discharges (HP:0011182) | 2.75934568 |
| 29 | Gait imbalance (HP:0002141) | 2.72675640 |
| 30 | Hyperventilation (HP:0002883) | 2.71315049 |
| 31 | Ankle clonus (HP:0011448) | 2.71243985 |
| 32 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.66485312 |
| 33 | Hypsarrhythmia (HP:0002521) | 2.62658858 |
| 34 | EEG with generalized epileptiform discharges (HP:0011198) | 2.62372914 |
| 35 | Hematochezia (HP:0002573) | 2.61436724 |
| 36 | Papilledema (HP:0001085) | 2.59318486 |
| 37 | Dialeptic seizures (HP:0011146) | 2.51667513 |
| 38 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.50618232 |
| 39 | Absence seizures (HP:0002121) | 2.49498243 |
| 40 | Action tremor (HP:0002345) | 2.49360580 |
| 41 | Abnormal hair whorl (HP:0010721) | 2.45421786 |
| 42 | Enlarged penis (HP:0000040) | 2.45198128 |
| 43 | Absent speech (HP:0001344) | 2.39117097 |
| 44 | Neurofibrillary tangles (HP:0002185) | 2.35168114 |
| 45 | Status epilepticus (HP:0002133) | 2.34713994 |
| 46 | Specific learning disability (HP:0001328) | 2.32211303 |
| 47 | Buphthalmos (HP:0000557) | 2.30226876 |
| 48 | Failure to thrive in infancy (HP:0001531) | 2.28718563 |
| 49 | Torticollis (HP:0000473) | 2.25661456 |
| 50 | Visual hallucinations (HP:0002367) | 2.24521585 |
| 51 | Agitation (HP:0000713) | 2.23330115 |
| 52 | Insidious onset (HP:0003587) | 2.22995049 |
| 53 | Termporal pattern (HP:0011008) | 2.22995049 |
| 54 | Hamartoma of the eye (HP:0010568) | 2.22592537 |
| 55 | Lissencephaly (HP:0001339) | 2.20728276 |
| 56 | Mitral valve prolapse (HP:0001634) | 2.20589471 |
| 57 | Cerebral aneurysm (HP:0004944) | 2.20073153 |
| 58 | Abnormality of the labia minora (HP:0012880) | 2.18907283 |
| 59 | Visceral angiomatosis (HP:0100761) | 2.17460686 |
| 60 | Postural instability (HP:0002172) | 2.17300479 |
| 61 | Hypoplasia of the brainstem (HP:0002365) | 2.16909268 |
| 62 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 2.16909268 |
| 63 | Mutism (HP:0002300) | 2.16699110 |
| 64 | Abnormality of the lower motor neuron (HP:0002366) | 2.16652189 |
| 65 | Hyperacusis (HP:0010780) | 2.14832711 |
| 66 | Lower limb asymmetry (HP:0100559) | 2.14024579 |
| 67 | Dysmetric saccades (HP:0000641) | 2.13177538 |
| 68 | Hand muscle atrophy (HP:0009130) | 2.12066533 |
| 69 | Ketoacidosis (HP:0001993) | 2.11897599 |
| 70 | Spastic tetraplegia (HP:0002510) | 2.10495979 |
| 71 | Elfin facies (HP:0004428) | 2.09123051 |
| 72 | Shallow orbits (HP:0000586) | 2.07732176 |
| 73 | Rectal prolapse (HP:0002035) | 2.07287704 |
| 74 | Amblyopia (HP:0000646) | 2.07175941 |
| 75 | Peripheral hypomyelination (HP:0007182) | 2.05718904 |
| 76 | Hemangiomatosis (HP:0007461) | 2.05388010 |
| 77 | Ankyloglossia (HP:0010296) | 2.04769983 |
| 78 | Intention tremor (HP:0002080) | 2.04491405 |
| 79 | Aortic aneurysm (HP:0004942) | 2.04411830 |
| 80 | Pachygyria (HP:0001302) | 2.03924238 |
| 81 | Fetal akinesia sequence (HP:0001989) | 2.02945940 |
| 82 | Abnormality of chloride homeostasis (HP:0011422) | 1.99978713 |
| 83 | Deep venous thrombosis (HP:0002625) | 1.99891985 |
| 84 | Sporadic (HP:0003745) | 1.97433453 |
| 85 | Exostoses (HP:0100777) | 1.97023347 |
| 86 | Lower limb muscle weakness (HP:0007340) | 1.96837535 |
| 87 | Medial flaring of the eyebrow (HP:0010747) | 1.95993757 |
| 88 | Nephrogenic diabetes insipidus (HP:0009806) | 1.95235309 |
| 89 | Oligodactyly (hands) (HP:0001180) | 1.95177298 |
| 90 | Abnormality of salivation (HP:0100755) | 1.94301004 |
| 91 | Disinhibition (HP:0000734) | 1.93874427 |
| 92 | Hypokalemic alkalosis (HP:0001949) | 1.91991184 |
| 93 | Vascular tortuosity (HP:0004948) | 1.91572847 |
| 94 | Hypoplasia of the corpus callosum (HP:0002079) | 1.90370407 |
| 95 | Cerebral inclusion bodies (HP:0100314) | 1.90149697 |
| 96 | Long toe (HP:0010511) | 1.89791955 |
| 97 | Congenital primary aphakia (HP:0007707) | 1.89679572 |
| 98 | Shawl scrotum (HP:0000049) | 1.89671767 |
| 99 | Broad metatarsal (HP:0001783) | 1.89614520 |
| 100 | Hip dysplasia (HP:0001385) | 1.89108872 |
| 101 | Increased CSF protein (HP:0002922) | 1.88974138 |
| 102 | Retinal dysplasia (HP:0007973) | 1.88715549 |
| 103 | Complement deficiency (HP:0004431) | 1.88607291 |
| 104 | Thin bony cortex (HP:0002753) | 1.88481672 |
| 105 | Distal upper limb amyotrophy (HP:0007149) | 1.87395129 |
| 106 | Upper limb amyotrophy (HP:0009129) | 1.87395129 |
| 107 | Urinary urgency (HP:0000012) | 1.87381878 |
| 108 | Arterial tortuosity (HP:0005116) | 1.85344530 |
| 109 | Metabolic alkalosis (HP:0200114) | 1.82870056 |
| 110 | Aneurysm (HP:0002617) | 1.82579280 |
| 111 | Turricephaly (HP:0000262) | 1.82283740 |
| 112 | Back pain (HP:0003418) | 1.81683660 |
| 113 | Thyroid-stimulating hormone excess (HP:0002925) | 1.81561510 |
| 114 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.77719713 |
| 115 | Stereotypic behavior (HP:0000733) | 1.77690715 |
| 116 | Viral hepatitis (HP:0006562) | 1.76445134 |
| 117 | Exotropia (HP:0000577) | 1.76275582 |
| 118 | Hepatoblastoma (HP:0002884) | 1.75845773 |
| 119 | Protruding tongue (HP:0010808) | 1.75715509 |
| 120 | Bronchomalacia (HP:0002780) | 1.75696460 |
| 121 | Focal dystonia (HP:0004373) | 1.75113139 |
| 122 | Hemiplegia (HP:0002301) | 1.74500691 |
| 123 | Dysdiadochokinesis (HP:0002075) | 1.74445936 |
| 124 | Intellectual disability, severe (HP:0010864) | 1.74189899 |
| 125 | Ketosis (HP:0001946) | 1.72091034 |
| 126 | Asymmetric growth (HP:0100555) | 1.71192647 |
| 127 | Hemiparesis (HP:0001269) | 1.70555988 |
| 128 | Striae distensae (HP:0001065) | 1.70527768 |
| 129 | Disproportionate tall stature (HP:0001519) | 1.70158964 |
| 130 | Hypercortisolism (HP:0001578) | 1.69578330 |
| 131 | Genital tract atresia (HP:0001827) | 1.69502418 |
| 132 | Asymmetry of the thorax (HP:0001555) | 1.69270326 |
| 133 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.69054761 |
| 134 | Impaired vibratory sensation (HP:0002495) | 1.68463730 |
| 135 | Cortical dysplasia (HP:0002539) | 1.68143855 |
| 136 | Anxiety (HP:0000739) | 1.67690996 |
| 137 | Poor suck (HP:0002033) | 1.67658778 |
| 138 | Vaginal atresia (HP:0000148) | 1.67377439 |
| 139 | Hallux valgus (HP:0001822) | 1.67207818 |
| 140 | Papillary thyroid carcinoma (HP:0002895) | 1.65381139 |
| 141 | Fibrous tissue neoplasm (HP:0012316) | 1.65298464 |
| 142 | Deviation of the hallux (HP:0010051) | 1.65054071 |
| 143 | Abnormality of the aortic arch (HP:0012303) | 1.64771191 |
| 144 | Poor coordination (HP:0002370) | 1.64135049 |
| 145 | Paraplegia (HP:0010550) | 1.63722360 |
| 146 | Epidermoid cyst (HP:0200040) | 1.63463047 |
| 147 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.63188183 |
| 148 | Poor eye contact (HP:0000817) | 1.63078409 |
| 149 | Inappropriate behavior (HP:0000719) | 1.62775811 |
| 150 | Neoplasm of the heart (HP:0100544) | 1.62419650 |
| 151 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.62152231 |
| 152 | Difficulty running (HP:0009046) | 1.62047279 |
| 153 | Conjunctival hamartoma (HP:0100780) | 1.61501990 |
| 154 | Renovascular hypertension (HP:0100817) | 1.60574208 |
| 155 | Myocardial infarction (HP:0001658) | 1.60502933 |
| 156 | Genetic anticipation (HP:0003743) | 1.60448769 |
| 157 | Subcapsular cataract (HP:0000523) | 1.60401534 |
| 158 | Fibroma (HP:0010614) | 1.60060175 |
| 159 | Insomnia (HP:0100785) | 1.59713953 |
| 160 | Abnormality of proline metabolism (HP:0010907) | 1.59160823 |
| 161 | Hydroxyprolinuria (HP:0003080) | 1.59160823 |
| 162 | Abnormal social behavior (HP:0012433) | 1.59063987 |
| 163 | Impaired social interactions (HP:0000735) | 1.59063987 |
| 164 | Obstructive sleep apnea (HP:0002870) | 1.58148661 |
| 165 | Hemorrhage of the eye (HP:0011885) | 1.57774075 |
| 166 | Obsessive-compulsive behavior (HP:0000722) | 1.56824694 |
| 167 | Bladder neoplasm (HP:0009725) | 1.55908688 |
| 168 | Bladder carcinoma (HP:0002862) | 1.55908688 |
| 169 | Congenital glaucoma (HP:0001087) | 1.55150100 |
| 170 | Megalencephaly (HP:0001355) | 1.54744873 |
| 171 | Hypoglycemic coma (HP:0001325) | 1.53785128 |
| 172 | Skin nodule (HP:0200036) | 1.51845863 |
| 173 | Heterotopia (HP:0002282) | 1.51737706 |
| 174 | Abnormality of oral frenula (HP:0000190) | 1.50809166 |
| 175 | Hyperactive renin-angiotensin system (HP:0000841) | 1.50556640 |
| 176 | Dilatation of the ascending aorta (HP:0005111) | 1.50255906 |
| 177 | Germ cell neoplasia (HP:0100728) | 1.50166301 |
| 178 | Intellectual disability, profound (HP:0002187) | 1.49061284 |
| 179 | Increased circulating renin level (HP:0000848) | 1.48593657 |
| 180 | Cavernous hemangioma (HP:0001048) | 1.48559534 |
| 181 | Pointed chin (HP:0000307) | 1.48426883 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CASK | 4.16134674 |
| 2 | TRIB3 | 4.09210249 |
| 3 | PKN2 | 3.18455736 |
| 4 | CDK19 | 3.01826249 |
| 5 | RIPK1 | 2.95685997 |
| 6 | FGFR2 | 2.22266403 |
| 7 | MAPK13 | 2.21579191 |
| 8 | MAP3K10 | 2.20120178 |
| 9 | EPHA4 | 2.15432818 |
| 10 | EEF2K | 2.11840251 |
| 11 | DYRK2 | 2.10070370 |
| 12 | PTK6 | 2.01510147 |
| 13 | PDGFRA | 2.00347950 |
| 14 | MAP3K9 | 1.97273118 |
| 15 | KSR2 | 1.86034449 |
| 16 | RET | 1.77418471 |
| 17 | MAP3K2 | 1.75977368 |
| 18 | MAP2K7 | 1.73367131 |
| 19 | PRKD3 | 1.72336840 |
| 20 | TNIK | 1.65902926 |
| 21 | CAMK1G | 1.63334832 |
| 22 | MARK1 | 1.61380756 |
| 23 | FRK | 1.59951317 |
| 24 | MARK2 | 1.57892534 |
| 25 | TYRO3 | 1.55635425 |
| 26 | SIK1 | 1.54409041 |
| 27 | FGFR3 | 1.47427663 |
| 28 | WNK4 | 1.46915524 |
| 29 | DAPK2 | 1.43652687 |
| 30 | SCYL2 | 1.40112263 |
| 31 | PNCK | 1.38754047 |
| 32 | KSR1 | 1.34996782 |
| 33 | CAMK1D | 1.31122180 |
| 34 | FGFR4 | 1.30725006 |
| 35 | EPHB2 | 1.29988439 |
| 36 | DYRK1A | 1.29271890 |
| 37 | ICK | 1.27892586 |
| 38 | LMTK2 | 1.25791961 |
| 39 | WNK1 | 1.21508803 |
| 40 | BCR | 1.20274724 |
| 41 | CAMKK1 | 1.18220645 |
| 42 | ERN1 | 1.17267419 |
| 43 | PINK1 | 1.16015611 |
| 44 | EPHB1 | 1.14673912 |
| 45 | PAK6 | 1.12694099 |
| 46 | SIK2 | 1.11172591 |
| 47 | PRKCG | 1.09238217 |
| 48 | NTRK1 | 1.05274206 |
| 49 | DMPK | 1.04382616 |
| 50 | SGK3 | 1.03475269 |
| 51 | PDGFRB | 1.02851011 |
| 52 | DYRK3 | 1.02136610 |
| 53 | TAOK1 | 1.01451108 |
| 54 | MINK1 | 1.00601210 |
| 55 | LRRK2 | 0.99910728 |
| 56 | ALK | 0.99814336 |
| 57 | PRKCH | 0.99239928 |
| 58 | TGFBR2 | 0.96039140 |
| 59 | MAP3K6 | 0.95162904 |
| 60 | CDK6 | 0.90572720 |
| 61 | CAMK1 | 0.89716680 |
| 62 | STK11 | 0.89550469 |
| 63 | PDK4 | 0.88384577 |
| 64 | PDK3 | 0.88384577 |
| 65 | MAP3K4 | 0.88203232 |
| 66 | NTRK2 | 0.87458738 |
| 67 | MAP2K4 | 0.86250151 |
| 68 | BMX | 0.84116248 |
| 69 | PRKD2 | 0.82138043 |
| 70 | EPHA3 | 0.80381581 |
| 71 | CDK14 | 0.80242878 |
| 72 | PTK2 | 0.79881375 |
| 73 | PAK3 | 0.78298247 |
| 74 | PDK1 | 0.76675353 |
| 75 | CDK11A | 0.76094431 |
| 76 | LATS1 | 0.75086821 |
| 77 | MAP3K7 | 0.74749022 |
| 78 | JAK2 | 0.74489328 |
| 79 | DDR2 | 0.74280459 |
| 80 | CDK18 | 0.74252743 |
| 81 | CDK15 | 0.74198039 |
| 82 | ERBB3 | 0.73715604 |
| 83 | NTRK3 | 0.72204523 |
| 84 | PDPK1 | 0.71910512 |
| 85 | STK39 | 0.69831632 |
| 86 | CAMK4 | 0.69607962 |
| 87 | PKN1 | 0.68619325 |
| 88 | FER | 0.67915994 |
| 89 | CAMKK2 | 0.67562132 |
| 90 | TRIM28 | 0.66050623 |
| 91 | JAK1 | 0.65809588 |
| 92 | SGK223 | 0.64464525 |
| 93 | SGK494 | 0.64464525 |
| 94 | CAMK2A | 0.62797401 |
| 95 | CDK5 | 0.62530625 |
| 96 | FGFR1 | 0.61901140 |
| 97 | DYRK1B | 0.61435708 |
| 98 | HIPK2 | 0.61107324 |
| 99 | MAP3K12 | 0.60571931 |
| 100 | STK24 | 0.59488489 |
| 101 | STK38 | 0.59105327 |
| 102 | CDK12 | 0.58160579 |
| 103 | CAMK2B | 0.57536017 |
| 104 | RIPK4 | 0.55968487 |
| 105 | MAPK12 | 0.55087838 |
| 106 | RPS6KA2 | 0.54461996 |
| 107 | SGK2 | 0.54450256 |
| 108 | MTOR | 0.54214947 |
| 109 | TNK2 | 0.54198406 |
| 110 | STK3 | 0.53864543 |
| 111 | PRKCZ | 0.53096459 |
| 112 | AKT3 | 0.52994654 |
| 113 | MAP3K1 | 0.51059257 |
| 114 | MAP3K11 | 0.50268670 |
| 115 | ERBB2 | 0.48878604 |
| 116 | WNK3 | 0.48369038 |
| 117 | UHMK1 | 0.48253379 |
| 118 | PRKAA1 | 0.46775151 |
| 119 | PRKD1 | 0.46175615 |
| 120 | SGK1 | 0.46113328 |
| 121 | GRK6 | 0.45342542 |
| 122 | OXSR1 | 0.45156274 |
| 123 | LATS2 | 0.44655538 |
| 124 | PLK2 | 0.44389762 |
| 125 | FYN | 0.42744262 |
| 126 | GSK3A | 0.42278748 |
| 127 | PRKCE | 0.42096126 |
| 128 | TESK1 | 0.41695570 |
| 129 | CSNK1G2 | 0.41373744 |
| 130 | FLT3 | 0.41333662 |
| 131 | SIK3 | 0.41078385 |
| 132 | STK10 | 0.40480136 |
| 133 | MAPK10 | 0.40468194 |
| 134 | RPS6KA3 | 0.40204321 |
| 135 | CSNK1A1L | 0.39870753 |
| 136 | TTN | 0.39651857 |
| 137 | PHKG1 | 0.39479882 |
| 138 | PHKG2 | 0.39479882 |
| 139 | PTK2B | 0.39356388 |
| 140 | PASK | 0.38790732 |
| 141 | CSNK1E | 0.38481766 |
| 142 | PRKG1 | 0.37744888 |
| 143 | PRKACA | 0.33961886 |
| 144 | GRK5 | 0.33875017 |
| 145 | TAOK3 | 0.33237247 |
| 146 | YES1 | 0.32954671 |
| 147 | MAPK4 | 0.32719284 |
| 148 | MAPK8 | 0.32433308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.98032223 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.70796899 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.48582632 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61696284 |
| 5 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.51821857 |
| 6 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.47982246 |
| 7 | Taste transduction_Homo sapiens_hsa04742 | 1.45606408 |
| 8 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.45297130 |
| 9 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.42081560 |
| 10 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.41031269 |
| 11 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.26770646 |
| 12 | Bile secretion_Homo sapiens_hsa04976 | 1.23908879 |
| 13 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.22714865 |
| 14 | Glioma_Homo sapiens_hsa05214 | 1.21813688 |
| 15 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.21663366 |
| 16 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.20804222 |
| 17 | Endometrial cancer_Homo sapiens_hsa05213 | 1.17292408 |
| 18 | Insulin resistance_Homo sapiens_hsa04931 | 1.15223161 |
| 19 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.13694726 |
| 20 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.10886189 |
| 21 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.10533699 |
| 22 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.10132772 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.09841165 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.08257629 |
| 25 | Long-term potentiation_Homo sapiens_hsa04720 | 1.07773087 |
| 26 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.07347553 |
| 27 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.07065371 |
| 28 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06562995 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.06418976 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.04446769 |
| 31 | Phototransduction_Homo sapiens_hsa04744 | 1.01144555 |
| 32 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.99913847 |
| 33 | Circadian rhythm_Homo sapiens_hsa04710 | 0.99615024 |
| 34 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.97613743 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.97395381 |
| 36 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.97264606 |
| 37 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.95532320 |
| 38 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.95258062 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.95162600 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94310280 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.93569857 |
| 42 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.93249306 |
| 43 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.92783425 |
| 44 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.91713537 |
| 45 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.90813511 |
| 46 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.90797431 |
| 47 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90641427 |
| 48 | Lysine degradation_Homo sapiens_hsa00310 | 0.90632008 |
| 49 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.90371169 |
| 50 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.90097342 |
| 51 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88204315 |
| 52 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87718541 |
| 53 | Salivary secretion_Homo sapiens_hsa04970 | 0.87516363 |
| 54 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.86839820 |
| 55 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.86344048 |
| 56 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85069708 |
| 57 | Focal adhesion_Homo sapiens_hsa04510 | 0.85051132 |
| 58 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.84811117 |
| 59 | Circadian entrainment_Homo sapiens_hsa04713 | 0.84291396 |
| 60 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84220721 |
| 61 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.84172643 |
| 62 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.84072871 |
| 63 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.82906428 |
| 64 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.82804168 |
| 65 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.82737989 |
| 66 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.81741309 |
| 67 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.81513486 |
| 68 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.81088262 |
| 69 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.80733084 |
| 70 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.80221816 |
| 71 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.80160218 |
| 72 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.78769749 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.78333170 |
| 74 | Axon guidance_Homo sapiens_hsa04360 | 0.77939335 |
| 75 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.77745642 |
| 76 | Colorectal cancer_Homo sapiens_hsa05210 | 0.77110129 |
| 77 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.76668432 |
| 78 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.76542534 |
| 79 | Insulin secretion_Homo sapiens_hsa04911 | 0.76139634 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.75107997 |
| 81 | Adherens junction_Homo sapiens_hsa04520 | 0.74644411 |
| 82 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74297861 |
| 83 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.72161761 |
| 84 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.70095664 |
| 85 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.67901389 |
| 86 | Gap junction_Homo sapiens_hsa04540 | 0.67823556 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.67540220 |
| 88 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67520609 |
| 89 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.67355346 |
| 90 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67222632 |
| 91 | Amoebiasis_Homo sapiens_hsa05146 | 0.66522153 |
| 92 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65922305 |
| 93 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.65677326 |
| 94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.65523128 |
| 95 | GABAergic synapse_Homo sapiens_hsa04727 | 0.65062364 |
| 96 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.65021918 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.64941803 |
| 98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.63405463 |
| 99 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63218674 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.62540571 |
| 101 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.62004854 |
| 102 | Endocytosis_Homo sapiens_hsa04144 | 0.61963076 |
| 103 | Melanogenesis_Homo sapiens_hsa04916 | 0.61841690 |
| 104 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61661607 |
| 105 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.61442345 |
| 106 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.61281863 |
| 107 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.60635866 |
| 108 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.60153152 |
| 109 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60024445 |
| 110 | Morphine addiction_Homo sapiens_hsa05032 | 0.59860059 |
| 111 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.59790045 |
| 112 | Cocaine addiction_Homo sapiens_hsa05030 | 0.59448096 |
| 113 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.59404807 |
| 114 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58896863 |
| 115 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.58857064 |
| 116 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.58598516 |
| 117 | Platelet activation_Homo sapiens_hsa04611 | 0.58587528 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57999240 |
| 119 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.57906872 |
| 120 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.57794890 |
| 121 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.56663281 |
| 122 | Long-term depression_Homo sapiens_hsa04730 | 0.56525386 |
| 123 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.56514584 |
| 124 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56276273 |
| 125 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.53817215 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.52579304 |
| 127 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.49724518 |
| 128 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.49073600 |
| 129 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.46495677 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45317238 |
| 131 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.44847183 |
| 132 | Parkinsons disease_Homo sapiens_hsa05012 | 0.43718885 |
| 133 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.40235814 |
| 134 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37259071 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35877863 |
| 136 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35855111 |
| 137 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.34157399 |

